Percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH [gonadotropin-releasing hormone] agonist or antagonist)
eMeasure ID
First Performance Year
2017
Last Performance Year
Metric Type
Single Performance Rate
National Quality Strategy Domain
ECC
Measure Type
Process
eMeasure UUID
NQF eMeasure ID
NQF ID
0390
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward
American Urological Association Education and Research